1. Home
  2. EVOK vs IBG Comparison

EVOK vs IBG Comparison

Compare EVOK & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • IBG
  • Stock Information
  • Founded
  • EVOK 2007
  • IBG 2018
  • Country
  • EVOK United States
  • IBG Australia
  • Employees
  • EVOK N/A
  • IBG N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • IBG Beverages (Production/Distribution)
  • Sector
  • EVOK Health Care
  • IBG Consumer Staples
  • Exchange
  • EVOK Nasdaq
  • IBG Nasdaq
  • Market Cap
  • EVOK 5.4M
  • IBG 5.4M
  • IPO Year
  • EVOK 2013
  • IBG 2024
  • Fundamental
  • Price
  • EVOK $5.21
  • IBG $0.36
  • Analyst Decision
  • EVOK
  • IBG Strong Buy
  • Analyst Count
  • EVOK 0
  • IBG 1
  • Target Price
  • EVOK N/A
  • IBG N/A
  • AVG Volume (30 Days)
  • EVOK 437.4K
  • IBG 514.0K
  • Earning Date
  • EVOK 11-06-2025
  • IBG 09-19-2025
  • Dividend Yield
  • EVOK N/A
  • IBG N/A
  • EPS Growth
  • EVOK N/A
  • IBG N/A
  • EPS
  • EVOK N/A
  • IBG N/A
  • Revenue
  • EVOK $12,794,859.00
  • IBG $2,931,243.00
  • Revenue This Year
  • EVOK $57.38
  • IBG N/A
  • Revenue Next Year
  • EVOK $59.57
  • IBG N/A
  • P/E Ratio
  • EVOK N/A
  • IBG N/A
  • Revenue Growth
  • EVOK 70.02
  • IBG N/A
  • 52 Week Low
  • EVOK $1.94
  • IBG $0.31
  • 52 Week High
  • EVOK $12.32
  • IBG $3.35
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 50.12
  • IBG 26.98
  • Support Level
  • EVOK $5.03
  • IBG $0.54
  • Resistance Level
  • EVOK $5.57
  • IBG $0.59
  • Average True Range (ATR)
  • EVOK 0.44
  • IBG 0.07
  • MACD
  • EVOK -0.09
  • IBG -0.01
  • Stochastic Oscillator
  • EVOK 11.17
  • IBG 14.25

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About IBG Innovation Beverage Group Limited Ordinary Shares

Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.

Share on Social Networks: